Exagen Inc.
XGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0.2% | 11% | 13.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 58.4% | 60.4% | 58.9% | 62.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -30.8% | -16.3% | -17.9% | -20.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -41.1% | -25.8% | -24.2% | -27.5% |
| EPS Diluted | -0.31 | -0.21 | -0.2 | -0.2 |
| % Growth | -47.6% | -5% | 0% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | $0 |